Dual GLP-1/GIP Agonists Tirzepatide is unique as it acts on both GLP-1 and GIP receptors
Discuss lifestyle factors like your typical diet, physical activity levels, sleep patterns, and stress levels, as these can influence both medication response and overall outcomes
KFF, Medicaid Coverage of and Spending on GLP-1s, 2026 Wegovy is FDA-approved for chronic weight management (BMI 30+, or 27+ with a weight-related comorbidity) and for cardiovascular risk reduction in adults with established CVD it is a weight-loss and CV drug, not a diabetes drug
Lotte Bjerre Knudsen and GLP-1 Under the leadership of President and CEO Lars Rebien Srensen, who took the helm in 2000, and led by chief scientist Lotte Bjerre Knudsen (more on her in a second), the company doubled down on its mission to conquer diabetes and related chronic diseases
SEMA was shown to be the most effective of its category in terms of meaningful weight reduction as it can penetrate certain areas in the central nervous system that are critical for hunger and appetite control and are not protected by the blood-brain barrier, regulating key appetite-modulating relay areas [70, 73]
